Smartwatch-supported Internet-delivered Intervention for Depression
Integration of a Smartwatch Within an Internet-delivered Intervention for Depression: a Feasibility Randomized Controlled Trial on Acceptance
1 other identifier
interventional
71
1 country
1
Brief Summary
The current study seeks to investigate the acceptance of the use of a smartwatch in an internet-delivered Cognitive Behavioural Therapy (CBT) based intervention for depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Nov 2020
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2020
CompletedFirst Posted
Study publicly available on registry
September 29, 2020
CompletedStudy Start
First participant enrolled
November 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedNovember 18, 2022
November 1, 2022
9 months
September 10, 2020
November 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient acceptance (questionnaire)
All participants will be asked to fill in the Acceptability Questionnaire (AQ) upon consent, at 3 weeks, and at 8 weeks. These measurement points are aligned with Nadal et al. (2020) Technology Acceptance Lifecycle model. The questionnaire is based on the acceptance factors identified by Kim \& Park (2012). The wording of the AQ is adapted to the technology in question (smartwatch vs mobile/desktop app). Participants will rate each statement on a 5-point Likert Scale. The 8-week AQ contains a series of open-ended questions for the smartwatch group to explore additional factors that might influence the watch app acceptance (privacy protection, resistance to change, etc.).
Upon consent, at 3 weeks, and at 8 weeks
Patient acceptance (interview)
Participants in the smartwatch group who have indicated consent in taking part in the follow-up interview will be contacted after answering the final acceptance questionnaire.
8 weeks
Patient acceptance (Satisfaction with Treatment measure)
The SAT (Richards et al, 2013) will be used to assess patient satisfaction with the intervention. This 5-item questionnaire has been used previously to evaluate different aspects of patient satisfaction and experience with the 'Space from Depression' intervention (Richards et al, 2013). Score varies from 0 to 20; a higher score indicates a better outcome. The score is informed by 2 open-ended questions at the end of the questionnaire.
Immediately after the intervention
Secondary Outcomes (4)
Patient Health Questionnaire-9 (PHQ-9)
Baseline - At every meeting between participant and supporter - Immediately after the intervention
Generalized Anxiety Disorder-7 (GAD-7)
Baseline - At every meeting between participant and supporter - Immediately after the intervention
Work and Social Adjustment Scale (WSAS)
Baseline - At every meeting between participant and supporter - Immediately after the intervention
Usage of the program
at treatment completion, in average 8 weeks.
Study Arms (2)
Smartwatch group
EXPERIMENTALiCBT intervention 'Space from Depression' with smartwatch as an additional means to self-report data on mood, sleep and physical activity in the 'Space from Depression' program (n=35).
Treatment as usual group
ACTIVE COMPARATORiCBT intervention 'Space from Depression' (n=35).
Interventions
This is a 7-module internet-based CBT program. The structure and content of the modules follow evidence-based CBT principles; they are structured to incorporate quizzes, videos, psychoeducational content and interactive tools, personalised homework suggestions and summaries. One of the interactive tools is the mood monitor, where users are encouraged to monitor their mood and reflect on several factors that might had influenced it. Clients are allocated to a psychological wellbeing practitioner (PWP). The PWP is responsible for monitoring and guiding the client's progress throughout the intervention. Over the course of the 8 week supported intervention period, on 6 separate occasions the PWP will review participants progress, leaving feedback for them and responding to the work they have completed. The basic share level allows PWP is to view users' goals for the week, key messages and progress points. Each PWP will provide post-session feedback of between 10 and 15 minutes per session.
The Mood Monitor watch app will allow in-the-moment self-report of patients' mood and automated monitoring of their sleep and activity level. This data will be integrated into the existing Mood Monitor tool within the participant's Space from Depression program. During the intervention, prompts to record mood data will appear on the watch app; participants will be encourage to choose the frequency and time ranges to receive prompts. The watch app main screen will provide a daily and weekly visualisation of participant's mood, bedtime, hours slept and steps count, and visual cues on their progress. Participants will receive encouragement prompts to reward frequent and consistent self-report of mood over time and a good sleep hygiene. Finally, the app "Tips to Stay Well" feature will allow participants to go through a list of lifestyle-related tips extracted from the Space from Depression program.
Eligibility Criteria
You may qualify if:
- Eligible for the internet-delivered CBT intervention 'Space from Depression'
- Own a compatible mobile device (iPhone 6 or upper)
You may not qualify if:
- Suicidal intent/ideation; score \>2 on PHQ-9 question 9
- Psychotic illness
- Alcohol or drug misuse
- Previous diagnosis of an organic mental health disorder
- Currently in psychological treatment for depression symptoms
- Unstable medication regimens
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Silver Cloud Healthlead
- University of Dublin, Trinity Collegecollaborator
- Berkshire Healthcare NHS Foundation Trustcollaborator
Study Sites (1)
Berkshire Healthcare NHS Foundation Trust
Bracknell, Berkshire, RG12 1BQ, United Kingdom
Related Publications (1)
Nadal C, Earley C, Enrique A, Vigano N, Sas C, Richards D, Doherty G. Integration of a smartwatch within an internet-delivered intervention for depression: Protocol for a feasibility randomized controlled trial on acceptance. Contemp Clin Trials. 2021 Apr;103:106323. doi: 10.1016/j.cct.2021.106323. Epub 2021 Feb 20.
PMID: 33621632DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Derek Richards, PhD
Silver Cloud Health
- PRINCIPAL INVESTIGATOR
Sarah Sollesse, MSc
Berkshire Healthcare NHS Foundation Trust
- STUDY CHAIR
Camille Nadal, MSc
University of Dublin, Trinity College
- STUDY CHAIR
Gavin Doherty, PhD
University of Dublin, Trinity College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2020
First Posted
September 29, 2020
Study Start
November 30, 2020
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
November 18, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share